Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Rev. invest. clín ; 71(5): 339-348, Sep.-Oct. 2019. tab, graf
Article in English | LILACS | ID: biblio-1289704

ABSTRACT

Background Over consumption of added sugar is associated with obesity, non-alcoholic fatty liver disease (NAFLD), and insulin resistance (IR). Objective The objective of the study was to study the insulin-like growth factor binding protein-1 (IGFBP-1) and NAFLD and their relationship with fructose consumption in children with obesity. Methods A cross-sectional study was carried out in children 6-11 years old with obesity. Anthropometric measurements, fructose consumption, glucose, lipid profile, insulin, and IGFBP-1 levels were evaluated; the homeostatic model assessment of IR (HOMA-IR) was used. NAFLD was evaluated by ultrasound. Results We studied 83 children with a mean age of 9.2 ± 1.3 years. About 93% of the girls presented IR and lower levels of IGFBP-1 (p = 0.0001). The group with the lower levels of IGFBP-1 had higher HOMA-IR (p = 0.000002); IGFBP-1 was associated with fructose consumption (r = −0.25; p = 0.03), body mass index (BMI) (r=−0.42; p = 0.02), and HOMA-IR (r=−0.61; p = 0.002). About 81% of the children were classified as having mild or moderate/severe NAFLD, and these groups had higher HOMA-IR (p = 0.036) and fructose consumption (p = 0.0014). Conclusions The girls had more metabolic alterations. The group with lower levels of IGFBP-1 (hepatic IR) was associated with higher BMI, HOMA-IR, and fructose consumption; the group with higher severity of NAFLD showed higher HOMA-IR and fructose consumption.


Subject(s)
Humans , Male , Female , Child , Insulin-Like Growth Factor Binding Protein 1/metabolism , Pediatric Obesity/epidemiology , Non-alcoholic Fatty Liver Disease/epidemiology , Fructose/administration & dosage , Severity of Illness Index , Insulin Resistance/physiology , Body Mass Index , Sex Factors , Cross-Sectional Studies , Pediatric Obesity/etiology , Non-alcoholic Fatty Liver Disease/physiopathology , Fructose/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL